Sean Gomes1, Gregory Cranney2, Michael Bennett3, Annette Li4, Robert Giles5. 1. Department of Cardiology, Prince of Wales Hospital and University of New South Wales, Sydney 2031, Australia sgomes@med.usyd.edu.au. 2. Department of Cardiology, Prince of Wales Hospital and University of New South Wales, Sydney 2031, Australia. 3. Department of Anaesthetics, Prince of Wales Hospital and University of New South Wales, Sydney 2031, Australia. 4. University of New South Wales, Sydney 2031, Australia. 5. Department of Cardiology, Prince of Wales Hospital, Sydney 2031, Australia.
Abstract
AIMS: Indications for cardiovascular implantable electronic devices continue to evolve, which has led to an increasing requirement for transvenous lead extraction. We explore the indications, complications, and success rates involved in the removal of pacemaker and implantable cardioverter-defibrillator (ICD) leads in a high-volume centre, over 20 years. METHODS AND RESULTS: We performed a retrospective analysis of all consecutive patients undergoing transvenous lead extraction by a single operator at a single centre between 1993 and 2012. Patient characteristics, indications, and outcomes were analysed. A total of 1006 leads were removed from 510 patients. Seventy-two per cent of patients were males. The mean age was 64 years (range 14-96). Indications included systemic infection (25%), pocket infection (40%), lead failure (26%), chronic pain (3%), and other (6%). Ninety-six per cent of leads were completely removed. There was one procedure-related death, and the major complication rate was 0.3%. Infection was the only identified predictor of increased complication (χ² for difference between groups 20, P< 0.0001). CONCLUSION: Pacing and ICD leads can be safely extracted with mechanical techniques. The presence of device infection appears to be the major predictor of procedural complications. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Indications for cardiovascular implantable electronic devices continue to evolve, which has led to an increasing requirement for transvenous lead extraction. We explore the indications, complications, and success rates involved in the removal of pacemaker and implantable cardioverter-defibrillator (ICD) leads in a high-volume centre, over 20 years. METHODS AND RESULTS: We performed a retrospective analysis of all consecutive patients undergoing transvenous lead extraction by a single operator at a single centre between 1993 and 2012. Patient characteristics, indications, and outcomes were analysed. A total of 1006 leads were removed from 510 patients. Seventy-two per cent of patients were males. The mean age was 64 years (range 14-96). Indications included systemic infection (25%), pocket infection (40%), lead failure (26%), chronic pain (3%), and other (6%). Ninety-six per cent of leads were completely removed. There was one procedure-related death, and the major complication rate was 0.3%. Infection was the only identified predictor of increased complication (χ² for difference between groups 20, P< 0.0001). CONCLUSION: Pacing and ICD leads can be safely extracted with mechanical techniques. The presence of device infection appears to be the major predictor of procedural complications. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Pamela Omdahl; Michael D Eggen; Matthew D Bonner; Paul A Iaizzo; Kent Wika Journal: Pacing Clin Electrophysiol Date: 2016-02-01 Impact factor: 1.976
Authors: Maria Carmo Pereira Nunes; Túlio Pinho Navarro; Mariana de Braga Lima Carvalho; Nicole de Paula Aarão Faleiro Maia; Ricardo Jayme Procópio; Teresa Cristina Abreu Ferrari Journal: Indian Pacing Electrophysiol J Date: 2016-08-20
Authors: Arwa Younis; Michael Glikson; Amit Meitus; Noga Arwas; Sharon Shalom Natanzon; Dor Lotan; David Luria; Roy Beinart; Eyal Nof Journal: PLoS One Date: 2019-04-29 Impact factor: 3.240
Authors: Paweł Stefańczyk; Dorota Nowosielecka; Łukasz Tułecki; Konrad Tomków; Anna Polewczyk; Wojciech Jacheć; Andrzej Kleinrok; Wojciech Borzęcki; Andrzej Kutarski Journal: Vasc Health Risk Manag Date: 2021-08-05